Press release
Emerging Trends Influencing The Growth Of The Inherited Retinal Disease Market: Innovation In Mutation-Agnostic Gene Therapy Shaping The Market
Inherited Retinal Disease
How Big Is the Inherited Retinal Disease Market Size Expected to Be by 2034?
The market size for inherited retinal diseases has seen robust growth in the past few years. It is projected to increase from $11.56 billion in 2024 to $12.58 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 8.8%. Factors contributing to the growth during the historical period include the implementation of gene therapy, regulatory benefits, an increase in patient registries, more clinical trials, and the enhancement of patient-centered solutions.
Expectations are high for significant expansion of the inherited retinal disease market in the coming years. It is forecasted to reach a value of $17.42 billion in 2029, with a compound annual growth rate (CAGR) of 8.5%. This projected growth during this period can be linked to factors such as the increased application of CRISPR, the advent of personalized treatments, a concentration on regenerative medicine, the rise of patient advocacy, and a commitment to enhancing patients' quality of life. The period is also anticipated to see key trends such as the advancement of optogenetics technology, the creation of artificial retina implants, the broadening of digital health platforms, the inclusion of artificial intelligence in disease modelling, and the application of artificial intelligence in treatment planning.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20850
What Are the Emerging Segments Within the Inherited Retinal Disease Market?
The inherited retinal disease market covered in this report is segmented -
1) By Type: Diagnosis, Therapy
2) By Disease Type: Retinitis Pigmentosa, Choroideremia, Stargardt Disease, Cone-rode Dystrophy, Leber Congenital Amaurosis, Other Diseases
3) By Distribution Channel: Retail Sales, Direct Tender
4) By End Users: Hospitals, Speciality Clinics, Ambulatory Surgical Centres, Home Healthcare, Other End Users
Subsegments,
1) By Diagnosis: Genetic Testing (Genetic Screening), Retinal Imaging (Fundus Photography, Optical Coherence Tomography (OCT)), Electrophysiological Testing (Electroretinography), Visual Field Testing, Fundus Autofluorescence Imaging
2) By Therapy: Gene Therapy, Stem Cell Therapy, Retinal Prosthesis (Artificial Retina), Pharmacological Therapy (Gene Editing, Retinal Drugs), Photoreceptor Rescue Therapy
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20850&type=smp
What Long-Term Drivers Are Shaping Inherited Retinal Disease Market Trends?
The inherited retinal disease market is expected to surge as macular degeneration becomes more prevalent. This age-linked eye disorder that impairs the macula leads to central vision loss and impedes activities like reading or facial recognition. The surge in macular degeneration can be attributed to an aging population, increased life expectancy, and lifestyle habits such as smoking and inadequate nutrition that heighten risk. Treatment of inherited retinal disease aids patients with macular degeneration by focusing on the genetic roots of retinal degeneration. This offers therapies that slow down the disease's advancement, restore lost vision, and potentially prevent additional retina damage, ultimately enhancing visual outcomes and the life quality of individuals afflicted by age-related or inherited macular degeneration. For example, the Canadian Ophthalmological Society, a nonprofit residing in Canada, documented in February 2024 that 2.5 million Canadians over the age of 55 lost their eyesight due to age-related macular degeneration (AMD). This surge in macular degeneration cases is a driving force for the inherited retinal disease market's growth.
Who Are the Top Competitors in Key Inherited Retinal Disease Market Segments?
Major companies operating in the inherited retinal disease market are Johnson & Johnson, Novartis AG, Astellas Pharma Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Invitae Corporation, Spark Therapeutics, Aldeyra Therapeutics, Regenxbio Inc., IVERIC bio, MeiraGTx Limited, Ocugen Inc., Coave Therapeutics, Bionic Vision Technologies, GenSight Biologics SA, LKC Technologies Inc., Sparing Vision, ProQR Therapeutics NV, Endogena Therapeutics
What Actigraphy Devices Market Trends Are Gaining Traction Across Different Segments?
Leading companies in the inherited retinal diseases marketplace are concentrating on the development of groundbreaking treatments such as mutation-agnostic gene therapy. This strategy aims to provide comprehensive care and address various genetic mutations associated with these diseases. Unlike targeted genetic treatments, Mutation-agnostic gene therapy targets larger genetic mechanisms, proving useful across a spectrum of genetic disorders. For instance, Nanoscope Therapeutics Inc, a biotech company from the US, broadcasted positive findings from a clinical trial involving their main program, MCO-010 in March 2024. The program showed improvements in vision for those suffering from advanced retinitis pigmentosa, leading to severe and permanent vision loss. MCO-010 met its primary and important secondary objectives while demonstrating statistical significance and encountering no severe side effects.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/inherited-retinal-disease-global-market-report
Which Regions Are Becoming Hubs for Inherited Retinal Disease Market Innovation?
North America was the largest region in the inherited retinal disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inherited retinal disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Inherited Retinal Disease Market?
2. What is the CAGR expected in the Inherited Retinal Disease Market?
3. What Are the Key Innovations Transforming the Inherited Retinal Disease Industry?
4. Which Region Is Leading the Inherited Retinal Disease Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.
Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Emerging Trends Influencing The Growth Of The Inherited Retinal Disease Market: Innovation In Mutation-Agnostic Gene Therapy Shaping The Market here
News-ID: 4067163 • Views: …
More Releases from The Business Research Company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for Retina
Visual Prosthesis Market | Bionic Vision, Nano Retina, PIXIUM VISION, Retina Imp …
The global visual prosthesis market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the visual prosthesis market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth of the…
Artificial Retina Market Revenue 2019: Nano-Retina, Second Sights
Product innovation is a key artificial retina market trend. The ophthalmic industry has become more competitive over the last few years. Established ophthalmic product categories have become more mature, in turn offering low level of market opportunity for players. Most companies are emphasizing on price level strategy in order to enhance their business presence worldwide. However, the pricing trend could potentially benefit the company on a shorter scale during the…
Artificial Retina Market Key Players – Second Sight, Nano Retina, Retina Impla …
Artificial Retina manufacturers are making huge financial investments in R&D which is leading to new and innovative product development resulting in driving the growth for the market in turn. According to a recent study report published by the Market Research Future, The Global Market of Artificial Retina is growing steadily and is expected to continue its growth soon. Global Artificial Retina Market is expected to grow to US$ 102.9 million…
Artificial Retina Market 2018: Advancement with Key Player – Second Sight, Nan …
Artificial Retina is new hope for blind people and helps blind person to see objects. Artificial retina is placed either in the internal surface of the retina or outer surface of retina. There are around 1.5 million people suffering from retinitis pigmentosa which ultimately causes blindness. Approximately, 280 million people with visual impairment and about 40 million people are completely blind.
Global Artificial Retina Market - Key Players
Some of the…
Artificial Retina Market Insights With Key Players Nano-Retina, Second Sights, a …
Artificial retina market is a major breakthrough in medical devices industry, wherein many universities and leading medical devices companies are conducting research to offer vision to over 285 million visually impaired population worldwide. These devices are mainly nanorod carbon nanotube biomimetic films along with accessory devices such as transmitter and video processing unit (VPU). As such progressive development towards artificial retina is expected to create high ROI for engaged…
Artificial Retina Market Unique Scenario by Key Vendors Like: Second Sight, Nano …
Global Market for Artificial Retina is growing steady and expected to continue its growth near future. Global Artificial Retina Market is expected to grow US$ 102.9 million by 2023 at CAGR of 2.1%.
Global Artificial Retina Market - Key Players
Some of the key players in this market are:
Second Sight (US)
Nano Retina (Israel)
Retina Implant AG (Germany)
Pixium Vision (France)
Bionic Vision Australia
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/2812
Global Artificial Retina Market - Segments
Global Artificial Retina…
